Results 1 to 10 of about 6,032 (153)

Flow diverter therapy for mirror-like aneurysms at the middle cerebral artery trifurcation: a case report. [PDF]

Front Surg
Zheng L, Yu J.
europepmc   +1 more source

Predictors of infarction and outcomes in capsular warning syndrome: a retrospective observational study. [PDF]

Front Neurol
Guo RX, Wang T.
europepmc   +1 more source

Drug response testing for elective carotid artery stenting: Prevalence of non-response to aspirin and clopidogrel and influence on post-interventional occurrence of cerebral ischemia. [PDF]

Neuroradiol J
Yousefi F, Hasan D, De Beukelaer F, Ridwan H, Nikoubashman O, Wiesmann M, Weyland CS.   +6 more
europepmc   +1 more source

Severe tirofiban-induced thrombocytopenia following percutaneous coronary intervention. [PDF]

J Cardiol Cases
Sousou JM, Ali K, O'Brien MC, Williams JM, Kandah F, Franchi F.   +5 more
europepmc   +1 more source

The Impact of Cangrelor in the UK for the Treatment of STEMI Patients with Gastric Absorption Issues Undergoing Percutaneous Coronary Intervention. [PDF]

J Clin Med
Modi B, Cain R, Stork R, Tarpey G, Colucciello A, Olivier D, Barwood C, Wright W, McAtamney R.   +8 more
europepmc   +1 more source

Tirofiban

Drugs of Today, 1999
Tirofiban is an antagonist of the gpIIb/IIIa receptor. It was developed as an intravenous agent for rapid, potent and reversible inhibition of platelet aggregation. It produces dose-related inhibition of aggregation. Its efficacy has been demonstrated in disease states associated with intravascular thrombus formation, such as occurs with unstable ...
openaire   +2 more sources

Tirofiban

Reactions Weekly
  +11 more sources

Tirofiban

Reactions Weekly, 2007
  +5 more sources